It is a known fact that if we are to stop the spread of COVID-19 around the world, low-income countries must be part of the solution by having the capacity to immunize their citizens.
A disturbing report released by Amnesty International on September 22 (“New report shows leading COVID-19 vaccine pharmaceutical companies fueling unprecedented human rights crisis”) describes these companies’ resistance to in-country distribution low income. According to the report, “Pfizer and BioNTech have so far delivered nine times more vaccines to Sweden alone than to all low-income countries combined – less than 1% of their production so far. … Companies are expected to achieve sales of $ 86 billion in 2022. “
Additionally, although “most companies (received) billions of dollars in government funding and advance orders, vaccine developers have monopolized intellectual property, blocked technology transfers, and aggressively lobbied against measures that would increase the global manufacture of these vaccines.
It stands to reason that if these companies were funded by the government, there should have been a moral quid pro quo that intellectual rights and technology transfer would be part of the deal. Once again, Big Pharma has shown its true colors to the detriment of the poorest.